Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular characterization of epithelial-mesenchymal transition and medical treatment related-genes in non-functioning pituitary neuroendocrine tumors. | Front Endocrinol (Lausanne) | 2023 | 37033229 | PubTator, text mining | PubMed |
| Metastatic high-grade meningioma: A case report and review of risk factors for metastasis. | Neurooncol Adv | 2023 | 37025757 | PubTator, text mining | PubMed |
| Macrocycles in Drug Discovery─Learning from the Past for the Future. | J Med Chem | 2023 | 37017513 | PubTator, text mining | PubMed |
| Solitary metachronous adrenal metastasis after radical resection of gastric large cell neuroendocrine carcinoma: a case report and literature review. | J Int Med Res | 2023 | 37017400 | PubTator, text mining | PubMed |
| Characteristics of malignant tumors of digestive system and autoimmune diseases. | Front Genet | 2023 | 37007960 | PubTator, text mining | PubMed |
Case report: The stroma-rich variant of Castleman's disease of hyaline-vascular type with atypical stromal cell proliferation and malignant potential: An exceptional rare case occurred in mediastinal lymph node. | Front Oncol | 2023 | 37007164 | PubTator, text mining | PubMed |
| Single-centre experience with peptide receptor radionuclide therapy for neuroendocrine tumours (NETs): results using a theranostic molecular imaging-guided approach. | J Cancer Res Clin Oncol | 2023 | 37004598 | PubTator, text mining | PubMed |
| Recurrent parathyromatosis in a patient with concomitant MEN1 and CASR gene alterations: Clinical management of a case report and literature review. | Front Endocrinol (Lausanne) | 2023 | 36998475 | PubTator, text mining | PubMed |
| Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors. | Oncologist | 2023 | 36994847 | PubTator, text mining | PubMed |
| Case report: Coexistence of sigmoid tumor with unusual pathological features and multiple colorectal neuroendocrine tumors with lymph node metastases. | Front Oncol | 2023 | 36994194 | PubTator, text mining | PubMed |
| Somatostatin receptor 2 in 10 different types of human non-neoplastic gastrointestinal neuroendocrine cells. | Pathol Res Pract | 2023 | 36989844 | PubTator, text mining | PubMed |
| Development of the First 18F-Labeled Radiohybrid-Based Minigastrin Derivative with High Target Affinity and Tumor Accumulation by Substitution of the Chelating Moiety. | Pharmaceutics | 2023 | 36986687 | PubTator, text mining | PubMed |
| Tumour Heterogeneity and the Consequent Practical Challenges in the Management of Gastroenteropancreatic Neuroendocrine Neoplasms. | Cancers (Basel) | 2023 | 36980746 | PubTator, text mining | PubMed |
| The Surgical Management of Lung Neuroendocrine Neoplasms. | Cancers (Basel) | 2023 | 36980581 | PubTator, text mining | PubMed |
| Sinonasal Cancer: Improving Classification, Stratification and Therapeutic Options. | Cancers (Basel) | 2023 | 36980561 | PubTator, text mining | PubMed |
| Chronic Treatment with Somatostatin Analogues in Recurrent Type 1 Gastric Neuroendocrine Tumors. | Biomedicines | 2023 | 36979851 | PubTator, text mining | PubMed |
| Multiple micromeningiomas coexist with primary lung adenocarcinoma: A case report. | Thorac Cancer | 2023 | 36978209 | PubTator, text mining | PubMed |
| Approach to the Patient With Prolactinoma. | J Clin Endocrinol Metab | 2023 | 36974474 | PubTator, text mining | PubMed |
| Liver organoids: established tools for disease modeling and drug development. | Hepatol Commun | 2023 | 36972388 | PubTator, text mining | PubMed |
| Role of Hydrogen Sulfide and Hypoxia in Hepatic Angiogenesis of Portal Hypertension. | J Clin Transl Hepatol | 2023 | 36969894 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=33